How much revenue did Abbvie generate this year?
Abbvie has achieved a revenue of 55.65 B USD this year.
Abbvie Revenue 2024
Abbvie Revenue
55.65 B USD
Abbvie Dividend yield
3.56 %
Ticker
ABBV
ISIN
US00287Y1091
WKN
A1J84E
In 2024, Abbvie's sales reached 55.65 B USD, a 2.46% difference from the 54.32 B USD sales recorded in the previous year.
The Abbvie Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 64.95 | 55,57 |
| 2028e | 64.38 | 56,06 |
| 2027e | 62.03 | 58,19 |
| 2026e | 63.3 | 57,01 |
| 2025e | 59.08 | 61,09 |
| 2024e | 55.65 | 64,85 |
| 2023 | 54.32 | 66,45 |
| 2022 | 58.05 | 71,53 |
| 2021 | 56.2 | 69,19 |
| 2020 | 45.8 | 66,69 |
| 2019 | 33.27 | 77,14 |
| 2018 | 32.75 | 76,93 |
| 2017 | 28.22 | 74,63 |
| 2016 | 25.64 | 77,32 |
| 2015 | 22.86 | 80,31 |
| 2014 | 19.96 | 77,83 |
| 2013 | 18.79 | 75,62 |
| 2012 | 18.38 | 75,47 |
| 2011 | 17.44 | 73,64 |
| 2010 | 15.64 | 72,59 |
| 2009 | 14.21 | 71,46 |
Abbvie Aktienanalyse
What does Abbvie do?
Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. Abbvie ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Abbvie's Sales Figures
The sales figures of Abbvie originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Abbvie’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Abbvie's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Abbvie’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Abbvie Stock
How much was the turnover of the company Abbvie compared to the previous year?
The revenue of Abbvie has increased by 2.46% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Abbvie?
The revenue of Abbvie is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Abbvie measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Abbvie so important for investors?
The revenue of Abbvie is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Abbvie pay?
Over the past 12 months, Abbvie paid a dividend of 5.92 USD . This corresponds to a dividend yield of about 3.56 %. For the coming 12 months, Abbvie is expected to pay a dividend of 6.04 USD.
What is the dividend yield of Abbvie?
The current dividend yield of Abbvie is 3.56 %.
When does Abbvie pay dividends?
Abbvie pays a quarterly dividend. This is distributed in the months of August, November, February, May.
How secure is the dividend of Abbvie?
Abbvie paid dividends every year for the past 101 years.
What is the dividend of Abbvie?
For the upcoming 12 months, dividends amounting to 6.04 USD are expected. This corresponds to a dividend yield of 3.63 %.
In which sector is Abbvie located?
Abbvie is assigned to the 'Health' sector.
Wann musste ich die Aktien von Abbvie kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Abbvie from 5/15/2024 amounting to 1.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.
When did Abbvie pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Abbvie in the year 2023?
In the year 2023, Abbvie distributed 5.64 USD as dividends.
In which currency does Abbvie pay out the dividend?
The dividends of Abbvie are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Abbvie stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Abbvie
Our stock analysis for Abbvie Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbvie Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
